-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.ISIN US09061G1013-
Biomarin PharmaceuticalBörse Börse FrankfurtSymbol BM8
-
Biomarin PharmaceuticalBörse Börse BerlinSymbol BM8
-
Biomarin PharmaceuticalBörse Börse MünchenSymbol BM8
-
BIOMARIN PHARMACEUTICAL INCBörse Gettex System der Börse MünchenSymbol BM8
-
BIOMARIN PHARMACEUTICAL INCBörse Tradegate System der Deutsche Börse AG (60%)Symbol BM8
-
BIOMARIN PHARMACEUTICAL INCBörse Börse DüsseldorfSymbol BM8
-
BIOMARIN PHARMACEUTICAL INCBörse Börse StuttgartSymbol BM8
-
BIOMARIN PHARMACEUTICAL INCBörse Quotrix System der Börse DüsseldorfSymbol BM8
-
ISIN US09061G1013 WKN: 924801Symbol BMRN
-
Symbol BM8
-
USD
-
Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:
14.747.496.448 oder 12.105.000.000 oder 11.227.286.340
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
3.001 oder 3.045 Mitarbeiter
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
17.82 oder 13.5
Biomarin Pharmaceutical outperformed den DAX um +18 % vom 02.05.2014 bis 02.09.2022
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 66,42 EUR -0,30%
Aktionärsstruktur der BioMarin Pharmaceutical Inc
Portrait der Biomarin Pharmaceutical Aktie
Das Unternehmen BioMarin Pharmaceutical Inc aus USA beschäftigt 3.023 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie, Pharma tätig.
Die Biomarin Pharmaceutical Aktie konnte seit dem 02.05.2014 eine Rendite von 51% erwirtschaften.
Das Unternehmen BioMarin Pharmaceutical Inc ist in mehr als 30 ETFs enthalten und somit eine vermutlich durchschnittlich bekannte Aktie. Der Spitzenreiter VanEck Vectors Biotech ETF gewichtet Biomarin Pharmaceutical mit 2,72% im ETF.
Entdecke die 6 ETFs in denen BioMarin Pharmaceutical Inc am höchsten gewichtet ist Insgesamt in 30 ETFs enthalten
Dir gefallen die Informationen zu Biomarin Pharmaceutical?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Dir gefallen die Informationen zu Biomarin Pharmaceutical?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Dir gefallen die Informationen zu Biomarin Pharmaceutical?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Dir gefallen die Informationen zu Biomarin Pharmaceutical?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
27 News & Informationen zur Biomarin Pharmaceutical Aktie
Chardan Healthcare Acquisition 2 Corp. Announces Renovacor's Appointment of Matt Killeen, Ph.D., as Chief Scientific Officer
/PRNewswire/ — Renovacor, Inc. (“Renovacor”), an early–stage biotechnology company developing adeno-associated virus (AAV)–based gene therapies for…
BioMarin Pharmaceutical : to Participate in Three Upcoming Virtual Investor Conferences
SAN RAFAEL, Calif., Aug. 25, 2021 /PRNewswire/ — BioMarin Pharmaceutical Inc. today announced that management will participate in three upcoming virtual investor conferences. An audio webcast… | August 25, 2021
Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights
– $6.6 million in net revenue for the second quarter 2021 (624% increase from first quarter 2021) – – 415 patient start forms (PSFs) received for LUPKYNIS™…
EDGAR Filing Documents for 0001048477-21-000025
BioMarin Pharmaceutical Inc. (BMRN) CEO J.J. Bienaimé on Q2 2021 Results – Earnings Call Transcript
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q2 2021 Results Conference Call July 28, 2021 04:30 PM ET Company Participants Traci McCarty – VP, IR J.J.
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was s…
Analysts Estimate BioMarin Pharmaceutical (BMRN) to Report a Decline in Earnings: What to Look Out for
BioMarin (BMRN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EMA Validates BioMarin' MAA For Valoctocogene Roxaparvovec To Treat Severe Hemophilia A
(RTTNews) – The European Medicines Agency or EMA validated BioMarin Pharmaceutical Inc.'s (BMRN) Marketing Authorization Application or MAA for it…
10 Stocks Stanley Druckenmiller is Selling
In this article, we discuss the 10 stocks Stanley Druckenmiller is selling. If you want to skip our detailed analysis of Druckenmiller’s history, investment…
Where Do Hedge Funds Stand On Whirlpool Corporation (WHR)?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However…
S&P's Record Run Ends, but the NASDAQ Keeps Going
Stocks Analysis by Zacks Investment Research covering: Steel Dynamics Inc, Apple Inc, Amazon.com Inc, Cleveland-Cliffs Inc. Read Zacks Investment Research's latest article on Investing.com
Is The J.M. Smucker Company (SJM) Going to Burn These Hedge Funds?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However…
Locanabio Expands Leadership Team With Appointment Of Chief Scientific Officer And Chief Medical Officer
SAN DIEGO, July 6, 2021 /PRNewswire/ — Locanabio, Inc., an RNA-targeting gene therapy company focused on developing life-changing therapies for patients with
BioMarin Announces 12 Presentations at the International Society on Thrombosis and Haemostasis (ISTH) 2021 Virtual Congress
/PRNewswire/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced three oral presentations and nine poster presentations related to valoctocogene…
Sarepta, Vertex, Neurocrine: There’s Deep Value In These Beaten Down Healthcare Stocks
Our theme of Out Of Favor Health Care Stocks includes healthcare and pharma names that are seeing a disconnect between their financial performance and stock price returns. Specifically, the theme filters for healthcare companies that have grown revenue by at least 50% over the last three years…
BioMarin Pharmaceutical : Resubmits Marketing Authorization Application (MAA) to European Medicines Agency for Valoctocogene Roxaparvovec to Treat Severe Hemophilia A
SAN RAFAEL, Calif., June 28, 2021 /PRNewswire/ — BioMarin Pharmaceutical Inc. announced today that the company resubmitted a Marketing Authorization Application to the European Medicines Agency … | June 28, 2021
Global Phenylketonuria Treatment Market (2021 to 2026) – by Type, Route, End-user and Geography
DUBLIN, June 25, 2021 /PRNewswire/ — The 'Global Phenylketonuria Treatment Market (2021-2026) by Type, Route, End-user, Geography, Competitive An…
Hedge Funds Have Never Been This Bullish On Pool Corporation (POOL)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data….
Is PulteGroup, Inc. (PHM) A Good Stock To Buy?
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred…
Gritstone Announces Management Changes, Including
EMERYVILLE, Calif., June 23, 2021 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing next…
Hedge Funds Have Never Been This Bullish On Howmet Aerospace Inc. (HWM)
In this article we are going to use hedge fund sentiment as a tool and determine whether Howmet Aerospace Inc. (NYSE:HWM) is a good investment right now…
Parnassus Endeavor Fund Buys Verizon Communications Inc, S&P Global Inc, Omnicom Group Inc, Sells Micron Technology Inc, Applied Materials Inc, Lam Research Corp
Parnassus Endeavor Fund Buys Verizon Communications Inc, S&P Global Inc, Omnicom Group Inc, Sells Micron Technology Inc, Applied Materials Inc, Lam Research Corp, Stocks: HBI,ILMN,VZ,SPGI,OMC,BIIB,BMRN,NVS,MU,AMAT,LRCX,SC, release date:Apr 12, 2021
Rectangle Pattern Suggests a Momentous Move in BioMarin Pharmaceutical Stock Soon By StockNews
Rectangle Pattern Suggests a Momentous Move in BioMarin Pharmaceutical Stock Soon
BIOMARIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. – BMRN
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC , announces that KSF has commenced an investigation into BioMarin… | January 16, 2021
Stock Alert: BioMarin Pharma Tumbles 8%
Shares of BioMarin Pharmaceutical Inc. (BMRN) are falling more than 8 percent or $7.67 in Monday's morning trade at $82.19. Sunday, BioMarin announced positive phase 3 gene therapy trial results in adults with severe hemophilia A, noting that the study met all primary and secondary efficacy endpoints in one-year data set.
Primecap Curbs Holdings of Cree, BioMarin Pharmaceutical
Primecap Curbs Holdings of Cree, BioMarin Pharmaceutical, Stocks: CREE,BMRN,FGEN,LLY,ADBE,MSFT,BIIB,AMGN, PRIMECAP Management, release date:Jan 08, 2021
BioMarin, Alkermes, Ionis: Are These Health Care Stocks Set To Outperform In 2021?
Our theme of Out Of Favor Health Care Stocks includes health care names that have witnessed strong growth and improving fundamentals over the last few years but have still underperformed over 2020, partly due to Covid-19 related disruptions of the health care industry…